Biobanking 2019


On 14 & 15 February 2019, EPM Group will host the BioTech Pharma Summit: Biobanking 2019 in Porto, Portugal. This year event will bring together the world’s leading experts in biorepositories, policy makers, and scientific actors to strengthen knowledge in biobanking as well as explore future advances in the field of biosampling for precision medicine, drug development and health research.

The biobanking market is expected to reach USD 2.69 Billion by 2022 from USD 1.72 Billion in 2016 at a CAGR of 7.8%. Learn the current market trends and future challenges only at the Biobanking 2019

Our distinguished panel includes renowned clinicians, researchers, executives and technical professionals from the biopreservation industry as well as the pioneers for a worldwide human research resource. Moreover, the current era is flooded with new advanced technologies, which culminated with the proliferation of more Biobank institutes globally, acting as a clear indicator of a market growth in the field.

Geographically, the EMEA region is estimated to account for a market share of approximately 44% during the predicted period. The presence of a well-established biobanking system in the Nordic countries, such as Sweden, Norway, Denmark, Finland, and Iceland, is a significant factor that bolsters market growth in this region. This conference will gather biobanking leaders from the north, as well as from across the Atlantic, in order to zoom in the market prospects and understand the dynamics of this fast-paced growing industry.

Over 20 presentations and case studies focusing on the key areas of the biobanking industry including market access strategies, clinical development, commercialization, biostorage and biosampling-analytics at the Biobanking 2019

The BioTech Pharma Summit: Biobanking 2019 is the leading event to get through  the biobanking’s ever-thriving market and convenes key stakeholders from the field,  and innovator pharmaceutical manufacturers, payers, providers and patient advocates addressing timely challenges and best practices for biobanking product success.

We invite all the participants across the globe to join our scientific gathering in Porto, which aims to reveal the newest data and share innovative ideas from research area of bioengeneering and tissue preservation.


  • Present different types of biobanking and innovative models in precision medicine
  • Understand the opportunities and challenges of biosampling
  • Learn the latest technological methods and procedures for biopreservation, storage stability and validation, while naming evidence-based best practices
  • Explore new sample quality management systems, quality standards and accreditation
  • Learn how to maintain a sustainable infrastructure in biobanking
  • Debate the social and ethical challenges of biobanking for human research
  • Predict the market impact of biobanking in the next decade
  • Current market trends and future challenges for biobanking success
  • Biobanking development in emerging markets
  • Prognosis for the Global Biobanking market in an era of transformative new technologies
  • Commercial challenges and opportunities
  • Redesigning the biobanking business model
  • Clinical Trial Strategies in Biobanking and Drug Development
  • Determining the right investments & potential returns from Biobanks



The BioTech Pharma Summit: (EPM Group) are exclusive events designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. Chief Executives, Executive Directors, Vice Presidents, Heads and Team Leaders and Managers including:

  • Biobanking Researchers
  • Biobanking Faculty Members
  • Medical Colleges
  • Biobanking Associations and Societies
  • Training Institutes
  • Cryo storage Companies
  • Data Provacy and Management Companies
  • Security Officers
  • Global Biobanking Companies
  • Business Developers
  • Biobanking investors
  • Lab Managers
  • Biopharmaceuticals and Biologics Researchers
  • Molecular Technologies
  • Intellectual property
  • Legislation and Policy Advice
  • Legislation and Policy Advice
  • Drug and Safety Assessment
  • Market Strategy
  • Biopharmaceuticals
  • Chief Scientific Officer
  • Clinical Immunology
  • Drug Safety Assessment & Risk Management
  • Population and Disease Based biobanks
  • Bioinnovation
  • Intellectual property
  • Regulatory Affairs
  • Health Economics
  • Principal Scientists
  • Process Control and Analytical Technologies
  • Quality Affairs/ Quality Control
  • Regulatory Affairs
  • Regulatory Compliance
  • Legal Affairs
  • R & D
  • New Product Development
  • Quality Affairs/Quality Control
  • Health Economics
  • Process Control and Analytical Technologies

*For Group registration or Sponsorship/Exhibition enquires, please use the contact form below.

President of ESBB (European, Middle Eastern and African Society for Biopreservation and Biobanking), DE
Chief Scientific Officer at Coriell Institute for Medical Research, US
Director, Precision Pathology Biobanking Center at Memorial Sloan Kettering Cancer Center, US
Executive Director, Stanford Biobank and Clinical Research Services (CTRU) at Stanford Medicine, US
Senior professor at the Karolinska Institutet, SE
Executive Vice President at ISENET Biobanking, IT
Chief Operating Officer at Biobank Graz, AT
Biobank Consortia & Communications at Trans-Hit Biomarkers, UK
Managing Director at Biostór Ireland, IE
Biobank and Model Bank Director at ARC-NET: Centre for Applied Research on Cancer, IT
Senior Field Applications Specialist (FAS) at Fluidigm, FR
CEO at BioKryo GmbH, DE
Marybeth Joshi
Director, Biobank & Translational Research Core at Duke University Medical Center, US
Executive manager at Biobank AS, NO
Director, Head of Clinical Trials Biosample Mgmt. at Merck KGaA, DE
Head of the LIFE-Biobank and Preanalytical Laboratory at University Hospital Leipzig, DE
Project Manager at MRC HGU, University of Edinburgh, UK
Production Manager at NIBSC, UK
Svetlana Gramatiuk
President and Medical Director at Ukraine Association of Biobank, UA
Clinical Trial Biosample Manager at Merck KGaA, DE
Ali Ismail
Founder & Managing Director at Birka Biostorage, SE
Project Manager at Auria Biobank, FI
Senior Director, Biobank & Translational Research at Duke University School of Medicine, USA
Document Package
Buy Ticket

Access to all event presentations

*Subject to speaker's approval for distribution

TAP Portugal made a partnership with the “Biotech Pharma Summit 2019”, held in Porto, on February 14-15 de 2019, offering a discount to all the participants purchasing a flight from TAP website.

The promo code of this event should me mentioned during your reservation in order to this discount be applied.

  • Enter on the website
  • Choose your departure city and arrival city "Porto"
  • Insert the code in the “box congress code" : IT19TPCG35

If you are experiencing any difficulties, please contact

Important Information:

  1. The discount applicable to this event is only valid for bookings made through our website where payment must be made by credit card. Electronic tickets will always be issued.
  2. Reservations already made previously, as well as reservations made through travel agents or our branches can not benefit from the discount.
  3. The price visible at the end of the reservation process is the total amount to be paid, with the discount processed and taxes included. The discount will be applied on the rate, without the respective rates.
  4. The discount only applies to flights operated by TAP. Reservations made on code-share flights operated by other airlines or with flights wholly from other airlines may not benefit from the discount.
  5. The discount is not cumulative with any other, as well as, can not be used in resident / student / child / baby / senior fares, etc.
  6. The discount only applies to round-trip travel to the event.
  7. The reservation can be made at any time. The dates of travel must be comprised within 10 days before and 10 days after the dates of the event. The dates of the event must be included in the period of the trip.
  8. The discount is extendable to the companions of the participant.
  9. Conditions and restrictions regarding changes and refunds will always be those of the selected rate. Please check fare details before finalizing your reservation.